CES 2023: Competition Spikes In Cuffless Blood Pressure Monitoring

19 Jan 2023

In this final roundup of innovative health technologies showcased at CES 2023, Medtech Insight highlights three companies, Biobeat, Conneqt and Valencell, that are developing innovative technologies for cuffless blood pressure monitoring. Biobeat is the first company to receive US FDA clearance for a wearable to monitor blood pressure, but competition looms.

The global market for cuffless blood pressure monitoring devices is projected to reach $2.25bn by 2023, driven in part by the rising popularity and adoption of wearables, according to researchers.

At CES 2023, three companies, Biobeat, Conneqt and Valencell, showcased their innovative solutions for monitoring hypertension.